They just completed a large offering raising 65 million dollars in middle of Sept & stated s/b enough to get through FDA approval & ready their drug launch. The offering is the only reason it's this low & again Insiders bought 7.1 Million shares of this offering in addition to the millions of shares already owned. GLTY & make $$$$$$$$
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.